Aardvark Therapeutics (AARD) closed at $1.33 on November 13, 2026, down 12.5% from the previous close, on volume of 400,739 shares (30-day average 1,171,545).
Data as of November 13, 2026.
Aardvark Therapeutics GAAP EPS of -$0.88
Seeking Alpha News (Fri, 13-Nov 8:47 AM ET)
Aardvark Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
Globe Newswire (Fri, 13-Nov 8:00 AM ET)
Globe Newswire (Mon, 2-Nov 9:51 AM ET)
Globe Newswire (Fri, 30-Oct 8:55 AM ET)
Globe Newswire (Mon, 26-Oct 8:51 AM ET)
Globe Newswire (Fri, 23-Oct 7:00 AM ET)
Globe Newswire (Thu, 22-Oct 4:05 PM ET)
Market Chameleon (Wed, 21-Oct 6:33 AM ET)
Globe Newswire (Wed, 21-Oct 8:24 AM ET)
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Aardvark Therapeutics trades on the NASDAQ stock market under the symbol AARD.
As of November 13, 2026, AARD stock price declined to $1.33 with 400,739 million shares trading.
AARD has a beta of 5.07, meaning it tends to be more sensitive to market movements. AARD has a correlation of 0.16 to the broad based SPY ETF.
AARD has a market cap of $29.11 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that AARD belongs to (by Net Assets): VTI, VXF, IBB, IWC, BUSM.
AARD has underperformed the market in the last year with a price return of -87.6% while the SPY ETF gained +11.5%. AARD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -79.8% and -7.6%, respectively, while the SPY returned -2.1% and -1.9%, respectively.
AARD support price is $1.36 and resistance is $1.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AARD shares will trade within this expected range on the day.
